Download presentation
Presentation is loading. Please wait.
1
MK-8628 augments T lymphocyte apoptosis.
MK-8628 augments T lymphocyte apoptosis. (A) Flow cytometry contour plots of annexin V and PI staining in anti-CD3/CD28 mAb–stimulated CD4+ and CD8+ T lymphocytes treated with 0.19 μM MK-8628 or untreated controls after 96 h. (B) Dose response depicting frequency of annexin V/PI, double-positive, late-stage apoptotic cells as show in (A). (C) Flow cytometry contour plots of the fluorescent pan-caspase inhibitor FITC-VAD-FMK in anti-CD3/CD28 mAb–stimulated CD4+ and CD8+ T lymphocytes treated with 0.19 μM MK-8628 or untreated controls after 96 h. (D) Dose response depicting frequency FITC-VAD-FMK positive cells as shown in (C). Data are from one experimental representative of at least three independent experiments and represent triplicate wells; small horizontal red lines indicate the mean. **p < 0.01, ***p < 0.001, ****p < , one-way ANOVA with posttest analysis. Peter Georgiev et al. ImmunoHorizons 2019;3: Copyright © 2019 The Authors
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.